1972
J. D. Kirkham et al.
FEATURE ARTICLE
13C NMR (100.6 MHz, CDCl3): 24.6, 84.5, 109.9, 119.0, 128.0,
128.1, 128.9, 129.6, 133.4, 138.3, 141.4, 151.9.
FTIR (CH2Cl2, thin film): 2981 (s), 2232 (m), 1332 (s), 1140 (s),
1048 (m), 847 cm–1 (s).
HRMS (ES+): m/z [M]+ calcd for C19H2011BNO2: 306.1665; found:
306.1664.
1H NMR (250 MHz, CDCl3): δ (7e/8e) = 0.38 (s, 9 H, SiCH3), 0.48
(s, 9 H, SiCH3), 1.39 (s, 12 H, CH3), 1.48 (s, 12 H, CH3), 7.71 (d,
J = 1.5 Hz, 1 H, HAr), 7.75 (d, J = 1.5 Hz, 1 H, HAr), 7.77 (d, J = 1.5
Hz, 1 H, HAr), 7.81 (d, J = 1.5 Hz, 1 H, HAr).
13C NMR (62.9 MHz, CDCl3): δ (7e/8e) = 0.0, 1.9, 25.5, 26.1, 85.1,
85.6, 113.5, 113.8, 117.6, 117.9, 127.9, 131.3, 131.5, 134.8, 135.2,
135.3, 136.5, 149.0.
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trimethylsi-
lyl)benzonitrile (7b) and 4-(4,4,5,5-Tetramethyl-1,3,2-dioxa-
borolan-2-yl)-3-(trimethylsilyl)benzonitrile (8b)
Using general procedure 2, with 2-pyrone 1e (25 mg, 0.21 mmol)
and alkyne 2b (94 mg, 0.42 mmol), gave the product (62 mg, 99%)
as a clear oil; inseparable mixture of 7b/8b (1:1).
FTIR (CH2Cl2, thin film): 2980 (s), 2229 (s), 1342 (s), 1143 cm–1
(s).
1H NMR (250 MHz, CDCl3): δ (7b/8b) = 0.37 (s, 18 H, SiCH3),
1.38 (s, 24 H, CH3), 7.60–7.73 (m, 3 H, HAr), 7.85 (d, J = 1.0 Hz, 1
H, HAr), 7.98 (d, J = 7.5 Hz, 1 H, HAr), 8.17 (d, J = 1.0 Hz, 1 H, HAr).
13C NMR (62.9 MHz, CDCl3): δ (7b/8b) = 0.0, 0.1, 24.7 (2 ×), 84.3
(2 ×), 111.6, 113.1, 118.8, 119.1, 130.6, 132.1, 134.3, 135.8, 137.0,
138.7, 148.4, 153.4.
HRMS (EI+): m/z [M]+ calcd for C16H2411BNO2Si: 302.1748; found:
302.1735.
HRMS (EI+): m/z [M]+ calcd for C16H2311B79BrNO2Si: 379.0774;
found: 379.0777.
3-Bromo-4-butyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzonitrile (7f) and 3-Bromo-5-butyl-4-(4,4,5,5-tetrameth-
yl-1,3,2-dioxaborolan-2-yl)benzonitrile (8f)
Using general procedure 2, with 2-pyrone 1f (25 mg, 0.13 mmol)
and alkyne 2c (54 mg, 0.26 mmol), gave the product (31 mg, 65%)
as a yellow oil; inseparable mixture of 7f/8f (11:1).
FTIR (CH2Cl2, thin film): 2977 (s), 2232 (m), 1337 (s), 1140 (s),
849 cm–1 (s).
1H NMR (250 MHz, CDCl3): δ (7f) = 0.97 (t, J = 7.0 Hz, 3 H,
CH2CH3), 1.28–1.30 (m, 2 H, CH2), 1.37 (s, 12 H, CH3), 1.45–1.49
(m, 4 H, CH2CH2CH3), 7.87 (d, J = 1.5 Hz, 1 H, HAr), 8.00 (d,
J = 1.5 Hz, 1 H, HAr).
13C NMR (62.9 MHz, CDCl3): δ (7f) = 13.8, 22.9, 24.8, 33.1, 35.2,
84.4, 110.6, 117.5, 125.5, 137.8, 138.6, 154.2.
HRMS (EI+): m/z [M]+ calcd for C17H2311B79BrNO2: 363.1005;
4-Butyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo-
nitrile (7c) and 3-Butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lan-2-yl)benzonitrile (8c)
Using general procedure 2, with 2-pyrone 1e (25 mg, 0.21 mmol)
and alkyne 2c (87 mg, 0.42 mmol), gave the product (32 mg, 53%)
as a yellow oil; inseparable mixture of 7c/8c (5:1).
found: 363.1003.
FTIR (CH2Cl2, thin film): 2959 (s), 2228 (s), 1600 (s), 1347 (s),
1144 cm–1 (s).
Trimethyl[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)prop-2-ynyl]silane (2d)
1H NMR (250 MHz, CDCl3): δ (7c) = 0.94 (t, J = 7.0 Hz, 3 H, CH3),
1.23–1.60 (m, 4 H, CH2), 1.36 (s, 12 H, CH3), 2.80–2.88 (m, 2 H,
CH2), 7.27 (d, J = 8.0 Hz, 1 H, HAr), 7.61 (dd, J = 8.0, 2.0 Hz, 1 H,
HAr), 8.07 (d, J = 2.0 Hz, 1 H, HAr); δ (8c) = 0.94 (t, J = 7.0 Hz, 3 H,
CH3), 1.23–1.60 (m, 4 H, CH2), 1.35 (s, 12 H, CH3), 2.80–2.88 (m,
2 H, CH2), 7.41–7.48 (m, 2 H, HAr), 7.84 (d, J = 8.0 Hz, 1 H, HAr).
13C NMR (62.9 MHz, CDCl3): δ (7c/8c) = 13.9 (2 ×), 22.6, 22.7,
24.9 (2 ×), 35.1, 35.2, 35.8 (2 ×), 84.1 (2 ×), 109.0 (2 ×), 119.1,
119.2, 128.1, 129.8, 132.2, 133.8, 136.3, 139.9, 155.5 (2 ×).
A 2.5 M soln of BuLi in hexanes (4.25 mL, 8.93 mmol), was added
dropwise to trimethylpropargylsilane (1.00 g, 8.93 mmol) in Et2O,
at –78 °C under N2. The resulting mixture was stirred at this temper-
ature for 1 h, then warmed to r.t. and stirred for 30 min. 2-Iso-
propoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.83 mL, 8.93
mmol), was added dropwise, and the resulting suspension stirred for
3 h. 1 M HCl in Et2O (11.61 mL, 11.61 mmol) was added dropwise,
and the reaction stirred for 1 h. Lithium salts were removed via fil-
tration through Celite under N2, and the product purified via recrys-
tallization (PE, bp 40–60 °C), affording 2d (840 mg, 40%) as a
colourless solid; mp 43–45 °C.
HRMS (ES+): m/z [M]+ calcd for C17H2411BNO2: 286.1978; found:
286.1965.
FTIR (CH2Cl2, thin film): 2982 (s), 2955 (s), 2197 (s), 1381 (s),
1312 cm–1 (s).
1H NMR (400 MHz, CDCl3): δ = 0.14 (s, 9 H, SiCH3), 1.28 (s, 12
H, CCH3), 1.62 (s, 2 H, SiCH2).
13C NMR (100.6 MHz, CDCl3): δ = –2.0, 8.6, 24.7, 83.8, 103.7.
2-Bromo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)biphe-
nyl-4-carbonitrile (7d)
Using general procedure 2, with 2-pyrone 1f (25 mg, 0.13 mmol)
and alkyne 2a (59 mg, 0.26 mmol), gave 7d (45 mg, 94%) as a yel-
low oil.
FTIR (CH2Cl2, thin film): 2979 (s), 2229 (w), 1590 (m), 1339 (s),
1142 cm–1 (s).
1H NMR (250 MHz, CDCl3): δ = 1.10 (s, 12 H, CH3), 7.19–7.26 (m,
2 H, HAr), 7.39–7.45 (m, 3 H, HAr), 7.91 (d, J = 1.5 Hz, 1 H, HAr),
7.99 (d, J = 1.5 Hz, 1 H, HAr).
13C NMR (62.9 MHz, CDCl3): δ = 24.5, 84.5, 112.4, 117.4, 124.3,
127.7, 128.1, 129.1, 136.2, 137.0, 140.6, 151.9.
HRMS (AP+): m/z [M]+ calcd for C12H23BO2Si: 239.1639; found:
239.1644.
Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-[(tri-
methylsilyl)methyl]benzoate (9) and Methyl 4-(4,4,5,5-Tetra-
methyl-1,3,2-dioxaborolan-2-yl)-3-[(trimethylsilyl)methyl]ben-
zoate (10)
Using general procedure 2, with 2-pyrone 1g (25 mg, 0.16 mmol)
and alkyne 2d (77 mg, 0.32 mmol), gave the product (22 mg, 41%)
as a yellow oil; inseparable mixture of 9/10 (6:1).
HRMS (EI+): m/z [M]+ calcd for C19H1911B79BrNO2: 383.0692;
found: 383.0680.
FTIR (CH2Cl2, thin film): 2976 (m), 2903 (w), 1722 (s), 1591 cm–1
(w).
1H NMR (250 MHz, CDCl3): δ (9) = 0.03 (s, 9 H, CH3), 1.36 (s, 12
H, SiCH3), 2.65 (s, 2 H, CH2SiCH3), 3.91 (s, 3 H, OCH3), 7.05 (d,
J = 8.0 Hz, 1 H, HAr), 7.95 (dd, J = 8.0, 2.0 Hz, 1 H, HAr), 8.44 (d,
J = 2.0 Hz, 1 H, HAr).
3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-
(trimethylsilyl)benzonitrile (7e) and 3-Bromo-4-(4,4,5,5-tetra-
methyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)benzonitrile
(8e)
Using general procedure 2, with 2-pyrone 1f (25 mg, 0.13 mmol)
and alkyne 2b (58 mg, 0.26 mmol), gave the product (46 mg, 96%)
as a clear oil; inseparable mixture of 7e/8e (1:1).
13C NMR (100.6 MHz, CDCl3): δ (9) = –1.6, 25.0, 27.5, 51.8, 83.6,
125.1, 128.6, 131.6, 137.8, 154.3, 164.6.
Synthesis 2012, 44, 1964–1973
© Georg Thieme Verlag Stuttgart · New York